disclosures
play

Disclosures Drug-induced Liver Disease: I have nothing to disclose. - PowerPoint PPT Presentation

5/26/2018 Disclosures Drug-induced Liver Disease: I have nothing to disclose. Problem Patterns Raga Ramachandran, MD PhD UCSF Pathology May 26, 2018 raga.ramachandran@ucsf.edu Acute liver failure Evaluating a liver biopsy for drug etiology


  1. 5/26/2018 Disclosures Drug-induced Liver Disease: I have nothing to disclose. Problem Patterns Raga Ramachandran, MD PhD UCSF Pathology May 26, 2018 raga.ramachandran@ucsf.edu Acute liver failure Evaluating a liver biopsy for drug etiology (Fulminant hepatitis) • Drug-induced liver injury can mimic any • Definition - onset of hepatic encephalopathy pattern of liver disease within 8 weeks of onset of symptoms • In most cases, unequivocal histological diagnosis is not possible • Often accompanied by massive/submassive • Incomplete drug history and multi-drug use necrosis complicate interpretation 1

  2. 5/26/2018 Drug-induced acute liver failure Pattern 1 has 3 patterns • • Extensive microvesicular steatosis (rare) Extensive microvesicular steatosis (rare) – Ex: Tetracycline, zidovudine (nucleoside analogs), valproate, L-asparaginase, amineptine • Necrosis with little or no inflammation • Necrosis with marked inflammation (most common) *Diagnostic pitfall – identifying macrovesicular (large and small droplet) and microvesicular steatosis Large and small droplet fat True microvesicular steatosis 2

  3. 5/26/2018 27-year-old man on entecavir (Baraclude) Extensive microvesicular steatosis • Mechanism – mitochondrial injury, may be accompanied by lactic acidosis • Morphology – little inflammation, variable cholestasis and necrosis • DDx – alcoholic foamy degeneration, Reye syndrome, acute fatty liver of pregnancy, Jamaican vomiting sickness (ackee fruit), urea cycle enzymatic deficiencies Patterns 2 and 3 Intrinsic vs. idiosyncratic hepatotoxicity • Necrosis with little or no inflammation • Intrinsic toxins (relatively few drugs) – Necrosis with little or no inflammation • Necrosis with marked inflammation (most common) – Damage in a predictable, dose-dependent manner by drug or its metabolite • Idiosyncratic hepatotoxins (most drugs) – Necrosis with marked inflammation – Metabolic (predisposed individuals) – Immunological (hypersensitivity) 3

  4. 5/26/2018 Acute acetaminophen toxicity Pattern 2 • Acute coagulative, perivenular (zone 3) to panacinar • Necrosis with little or no inflammation necrosis • Minimal to no inflammation; no fibrosis – Ex: Acetaminophen, cocaine, MDMA (Ecstasy), CCl 4 , mushroom alkaloids Pattern 3 Acute hepatitis • Necrosis with marked inflammation (most common) • The most common drug-related injury – Ex: Antimicrobials, MAO inhibitors, anticonvulsants, pattern seen on biopsy herbal and supplemental agents, potentially any drug Rest of differential that causes acute hepatitis • Acute viral hepatitis • Initial presentation of autoimmune hepatitis • Wilson disease • Up to 15% of cases progressing to fulminant hepatic failure are of unknown etiology 4

  5. 5/26/2018 Ketoconazole toxicity Submassive to massive necrosis • Early stage — necrosis • Subacute to late stage — regeneration with nodule formation *Diagnostic pitfall: distinguishing necrosis from fibrosis in persistent drug injury Severe active (subacute) hepatitis with diffuse small nodules mimicking cirrhosis Distinguishing fibrosis from necrosis Trichrome stain • Established fibrosis is uniformly dark blue • Elastic fiber bundles appear pale • Necrosis shows two-toned staining – Dense, darker, and thicker bundles of scar – Light, loose, and thinner bundles of residual framework and debris 5

  6. 5/26/2018 Trichrome, Cirrhosis Trichrome, Cirrhosis Severe acute hepatitis, trichrome: subacute stage Severe acute hepatitis, trichrome: subacute stage 6

  7. 5/26/2018 Trichrome, Late-stage submassive necrosis Trichrome, Two-toned staining Severe acute hepatitis, reticulin: early stage Fibrosis vs Necrosis Reticulin stain • Highlights cell plate framework – Regenerative plates – Collapsing plates – No distinct staining pattern for established scar 7

  8. 5/26/2018 Severe acute hepatitis: subacute stage Severe acute hepatitis, reticulin: subacute stage Reticulin, Cirrhosis Fibrosis vs Necrosis Elastic stains – Orcein • Highlights elastic fibers in later stages of fibrosis, as well as smaller elastic fibers in early stages of fibrosis 8

  9. 5/26/2018 Orcein in cirrhosis with elastic bundles Subacute hepatitis with prominent ductular reaction Orcein, Subacute Hepatitis Histochemical stains Necrosis Fibrosis H&E Dropout - Trichrome Two-tone blue All dark blue The only elastic fibers present are in Thin fibers Thicker bundles residual portal zones or central veins Reticulin Dropout/ - Collapse Orcein Negative Positive (elastic fibers) 9

  10. 5/26/2018 Lamotrigine-induced hepatitis Phenytoin-induced hepatitis Isoniazid-induced hepatitis Drugs that can mimic autoimmune hepatitis Methyldopa ANA (16%), ASMA (35%) Minocycline ANA, anti-DNA Nitrofurantoin ANA (80%), ASMA (72%) Oxyphenisatin ANA (67%), ASMA (67%) Statins ANA (80-90%) ASMA (25%) 10

  11. 5/26/2018 Methyldopa hepatitis Possible drug injury – herbals Trichrome stain – herbal history Herbals & supplements • An often overlooked source of liver injury • Not regulated by the FDA • >20,000 products marketed as powders, essential oils, teas • $5 billion spent annually purchasing herbals • Nearly 20% of Americans have used herbals • Herbal supplements may be contaminated by heavy metals (arsenic, lead, mercury, cadmium) 11

  12. 5/26/2018 Summary • Drug injury can mimic any pattern of primary liver disease – Careful clinical history is essential (including herbals) – Literature search can be useful • Acute liver failure (morphologic correlate of fulminant hepatitis) has 3 patterns: – Extensive microvesicular steatosis – Necrosis with little inflammation – Or necrosis with marked inflammation 12

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend